Deep Tissue Imaging
Closed Pre-Solicitation Posted
- Solicitation number
- 75N95025XXXX
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621512 Diagnostic Imaging Centers
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) National Institute on Drug Abuse is seeking information from institutions and companies with expertise and capabilities to enable deep tissue optical based imaging. This includes technologies such as adaptive optics, wavefront shaping, spatial light modulators, optics and artificial intelligence, optical imaging and deep learning, optical imaging and integrated circuits, multiscale imaging, synthetic wavelength technology and biophotonics. Respondents should provide contacts and describe their relevant capabilities, expertise, and organizational details. The pre-solicitation notice does not indicate any set-aside designations. Potential contract values or budget ranges are not provided, nor are any details on potential incumbent contractors. The pre-solicitation notice has a deadline of November 15, 2024 for responses.
Notice text
2 versions
Update #2 · Latest ·
Light attenuation in tissue due to scattering and absorption have limited the light penetration depth and the applications of optical imaging in biomedical and clinical research. NIH is seeking further information about the institutions and companies with expertise and capabilities to enable deep tissue optical based imaging. Examples of such technologies includes adaptive optics, wavefront shaping, spatial light modulators, optics and artificial intelligence, optical imaging and deep learning, optical imaging and integrated circuits, multiscale imaging, synthetic wavelength technology and biophotonics. Please provide contacts and describe your capabilities, expertise, and description of your organization.
Notice of Intent to Publish a Funding Opportunity Announcement for In Vivo Non-Invasive Optical Approaches for Biological systems (UG3/HU3 Clinical Trial Not Allowed)
NOT-RM-24-014 https://grants.nih.gov/grants/guide/notice-files/NOT-RM-24-014.html
Update #1 ·
Light attenuation in tissue due to scattering and absorption have limited the light penetration depth and the applications of optical imaging in biomedical and clinical research. NIH is seeking further information about the institutions and companies with expertise and capabilities to enable deep tissue optical based imaging. Examples of such technologies includes adaptive optics, wavefront shaping, spatial light modulators, optics and artificial intelligence, optical imaging and deep learning, optical imaging and integrated circuits, multiscale imaging, synthetic wavelength technology and biophotonics. Please provide contacts and describe your capabilities, expertise, and description of your organization.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories | National Institute on Drug Abuse | No set-aside | |
| RADx Coordination Center Notice of Intent | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity